June 15, 2023— Newly published research illustrates that while 340B hospitals tend to treat patients who are sicker and in greater need of care, they do not prescribe more expensive drugs than non-340B hospitals after those differences are taken into account. The latest evidence appears in the peer-reviewed Journal of the American Medical Association (JAMA). Researchers … [Read more...]
Research Continues to Illustrate 340B’s Valuable Role
October 20, 2022— A pair of new research reports adds to the growing body of evidence of the critical role 340B hospitals play in caring for patients living with low incomes. The research also demonstrates the crucial part these hospitals played in the initial stages of the COVID-19 pandemic. To qualify for 340B drug discounts, most hospitals must document that they serve a … [Read more...]
Research Shows 340B Meeting Its Mission
August 18, 2022— A pair of recent studies add to the growing body of research concluding that hospitals participating in the 340B drug pricing program are providing the lion’s share of care for patients who are most in need. These include people who cannot afford the services they need and people who historically have been underserved by the broader health care system. The … [Read more...]
340B Hospitals Are Key to the Pursuit of Health Equity
February 8, 2021– A global pandemic, an economic recession, and social strife in communities across the nation have cast a bright light on the deep racial and ethnic inequities in the U.S., starting a national dialogue that aspires to put us on a path toward real change. President Biden and his administration have made pursuing equity in health care and many other areas of our … [Read more...]
JAMA Study Shows 340B Can Help Restrain Drug Price Hikes
September 22, 2020— A recent Wall Street Journal opinion piece by a pharmaceutical industry consultant resurfaces claims that statutory discounts for safety-net hospitals, health centers, and clinics are forcing drug companies to hike their prices. Drug manufacturers are using this false notion as a pretext for urging program cutbacks in the guise of “reforms” and for refusing … [Read more...]
340B DSH Hospitals Provide Three-Quarters of Medicaid Hospital Services
July 16, 2020— New research shows that disproportionate share (DSH) hospitals that participate in the 340B drug pricing program provide 75% of Medicaid hospital services. That figure is even more impressive when you consider that these facilities make up only 43% of all acute care hospitals. This conclusion is one of several key findings in 340B Health’s new report … [Read more...]
340B Is a Cancer Lifeline for the Underserved
June 25, 2020— Although cancer can sicken and kill people of all races and ethnicities, disability statuses, and socioeconomic levels, it is a documented fact that members of certain underserved populations are more likely to have problems accessing cancer treatments and to have worse health outcomes. It is also a documented fact that hospitals participating in the 340B … [Read more...]